InMed Pharmaceuticals Statistics Share Statistics InMed Pharmaceuticals has 2M
shares outstanding. The number of shares has increased by -86.46%
in one year.
Shares Outstanding 2M Shares Change (YoY) -86.46% Shares Change (QoQ) 0% Owned by Institutions (%) 0% Shares Floating 1.99M Failed to Deliver (FTD) Shares 3,311 FTD / Avg. Volume 0.1%
Short Selling Information The latest short interest is 267.76K, so 13.37% of the outstanding
shares have been sold short.
Short Interest 267.76K Short % of Shares Out 13.37% Short % of Float 13.4% Short Ratio (days to cover) 1.19
Valuation Ratios The PE ratio is -0.37 and the forward
PE ratio is null.
InMed Pharmaceuticals's PEG ratio is
0.
PE Ratio -0.37 Forward PE n/a PS Ratio 0.61 Forward PS 0 PB Ratio 0.42 P/FCF Ratio -0.55 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for InMed Pharmaceuticals.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 4.41,
with a Debt / Equity ratio of 0.1.
Current Ratio 4.41 Quick Ratio 3.78 Debt / Equity 0.1 Debt / EBITDA -0.09 Debt / FCF -0.14 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $483.69K Profits Per Employee $-807.49K Employee Count 13 Asset Turnover 0.53 Inventory Turnover 3.84
Taxes Income Tax 9.71K Effective Tax Rate -0.09%
Stock Price Statistics The stock price has increased by -22.71% in the
last 52 weeks. The beta is 0.47, so InMed Pharmaceuticals's
price volatility has been higher than the market average.
Beta 0.47 52-Week Price Change -22.71% 50-Day Moving Average 2.76 200-Day Moving Average 3.47 Relative Strength Index (RSI) 34.3 Average Volume (20 Days) 3,201,591
Income Statement In the last 12 months, InMed Pharmaceuticals had revenue of 6.29M
and earned -10.5M
in profits. Earnings per share was -10.07.
Revenue 6.29M Gross Profit 1.51M Operating Income -11.12M Net Income -10.5M EBITDA -10.3M EBIT -11.12M Earnings Per Share (EPS) -10.07
Full Income Statement Balance Sheet The company has 6.57M in cash and 962.66K in
debt, giving a net cash position of 5.61M.
Cash & Cash Equivalents 6.57M Total Debt 962.66K Net Cash 5.61M Retained Earnings -109.08M Total Assets 9.28M Working Capital 4.57M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -6.99M
and capital expenditures -9.29K, giving a free cash flow of -7M.
Operating Cash Flow -6.99M Capital Expenditures -9.29K Free Cash Flow -7M FCF Per Share -9.18
Full Cash Flow Statement Margins Gross margin is 23.94%, with operating and profit margins of -176.92% and -166.94%.
Gross Margin 23.94% Operating Margin -176.92% Pretax Margin -166.79% Profit Margin -166.94% EBITDA Margin -163.77% EBIT Margin -176.92% FCF Margin -111.25%
Dividends & Yields INM does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for INM.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Nov 14, 2024. It was a
backward
split with a ratio of 1:20.
Last Split Date Nov 14, 2024 Split Type backward Split Ratio 1:20
Scores Altman Z-Score -18.94 Piotroski F-Score 1
